HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE
Objective. To perform health economic evaluation of several antirheumatic drugs in patients with rheumatoid arthritis (RA) progressed after DMARDs.Materials and methods. Three consequent line of rheumatoid arthritis therapy in patients progressed after methotrexate were modeled in Russian economic c...
Main Authors: | A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-12-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/154 |
Similar Items
-
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
by: Bruna O. Ascef, et al.
Published: (2021-07-01) -
Redução das imunoglobulinas induzida pelo abatacepte não se associa com eventos infecciosos
by: Valquiria Garcia Dinis
Published: (2017) -
Redução das imunoglobulinas induzida pelo abatacepte não se associa com eventos infecciosos
by: Dinis, Valquiria Garcia
Published: (2017) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01)